Fischer Medical Ventures partners with advisors to take its products from development to scale
India : Fischer Medical Ventures Limited (“FMV” or “the Group”) has appointed three Senior Advisors, Prof. Dr Zhe Lin, Prof Padmanabhan and Prof. Dr Iype Cherian.
India is the Group’s largest operating base. It is home to the Group’s manufacturing facility at the Andhra Pradesh MedTech Zone in Visakhapatnam, to Time Medical International Ventures, the Group’s material subsidiary and the first Indian company recognised by the Central Drugs Standard Control Organisation (CDSCO) for manufacturing MRI systems in India, and to companies in preventive and digital health and in life sciences.
Prof. Dr Parasuraman Padmanabhan
Prof. Dr Parasuraman Padmanabhan, PhD, FRSC, is a molecular imaging and nanomedicine researcher with over 30 years of experience across India, the USA, Singapore and, most recently, Hungary. Since June 2026 he has been Research Professor at the Faculty of Medicine, Semmelweis University, Budapest, in the Division of Neuroradiology. Before that he spent nearly a decade at the Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore, first as Deputy Director (2014 to 2017) and then as Senior Deputy Director (2017 to 2026). His earlier career includes Research Manager and Senior Research Fellow at the Singapore BioImaging Consortium (A*STAR), Director of a pre-clinical bioimaging centre, research roles at Stanford Medical School and Cornell University, and scientist positions at NEERI (CSIR) in India. He holds a PhD in Zoology from Annamalai University and was elected Fellow of the Royal Society of Chemistry in 2023.
His expertise covers cognitive neuroimaging, multimodal molecular imaging (MRI, PET, SPECT, MEG, fNIRS, EEG and optical), imaging probe development, nanotheranostics, drug discovery, stem cell and regenerative biology, and image processing. He has set up research facilities from scratch, including small animal, radioactive, cell and molecular biology, and bioimaging labs with MRI, PET, SPECT, CT and optical systems. He has held radioactive licences for about 20 years and has served on biosafety, fire safety, animal ethics, and health and safety committees. His research has attracted funding from MOE, A*STAR, NMRC and other Singapore agencies, as well as Indian, Austrian and Malaysian collaborative grants, with a focus on brain injury, neurodegeneration, cancer imaging and brain-computer interfaces.
He has published about 170 peer-reviewed papers, 20 book chapters, and an edited Springer volume on multimodal biomedical imaging (2025), with h-indices of 44 (Google Scholar) and 36 (Web of Science). His work has appeared in journals such as Science Translational Medicine, PNAS, Theranostics, ACS Nano and Acta Biomaterialia. He holds or has filed several patents, including quantum dots for stem cell labelling and sensing of beta-amyloid fibrillation. He is an editor for PLoS One, MDPI Cells, and the American Journal of Nuclear Medicine and Molecular Imaging, among others, and has guest-edited special issues in Nanomaterials and Cells. He also reviews for journals including ACS Nano, Small and Theranostics.He has taught medical imaging to undergraduate and PhD students at NTU since 2016, guided around 70 student theses and dissertations, and co-supervised 11 graduate students. He holds adjunct and visiting professorships at several Indian universities, including Saveetha, Bharat and Annamalai. His honours include the Academy of Molecular Imaging Young Investigator Award (2006) and the Innovative Guru Award (2021). He has given about 75 invited lectures, including at Karolinska Institute, and has organised international conferences and workshops. His collaborators include researchers at Stanford, Karolinska, Imperial College London, Aalto University and Eötvös Loránd University, and industry partners such as Mediso and Oncotherm.
Prof. Dr Lin Zhe
Prof. Dr. Zhe Lin is a scientist, inventor and serial entrepreneur specializing in biochip technologies, mechanobiology and AI-enabled medical diagnostics. He holds a Ph.D. in Medical Science and Technology from ETH Zurich, where he trained in a leading European mechanobiology laboratory, and a First-Class Honours degree in Bio-Engineering from Nanyang Technological University, Singapore. His academic and translational work sits at the intersection of biology, engineering, artificial intelligence and precision medicine.
As a co-founder and scientific leader of multiple deep-tech ventures, Prof. Lin has focused on converting advanced scientific discoveries into practical healthcare technologies. He is the CEO and Co-founder of Cell4D, developing mechanomics-based single-cell screening and sorting technology designed to enable label-free, real-time and high-throughput applications in cell therapy, drug discovery and precision medicine. He is also a Co-founder and Scientific Advisor to CVDetect, which combines proprietary biomarkers with AI-powered digital solutions for the real-time early detection of thrombosis and other time-critical diseases.
His technology portfolio spans single-cell screening, drug-resistant tumour-cell identification, precision oncology, antibody-drug screening, thrombosis detection and AI-enabled diagnostics. His work has also contributed to international collaborative research programmes involving institutions such as ETH Zurich, the Max Planck Institute and European research groups, including nanobiochip development for cardiac-tissue repair.
Prof. Lin’s work has received recognition from leading global accelerator and innovation programmes, including Merck Accelerator, Johnson & Johnson JLABS, MiraclePlus, MedTech Innovator APAC, Singapore Slingshot, Hong Kong JumpStarter and international innovation competitions. His portfolio also includes multiple inventions and patent applications covering cell identification, cellular traction-force measurement, biomarkers for thrombosis and infection, tissue engineering and medical applications.
Prof. Dr Iype Cherian
Dr. Iype Cherian, MCh (Neurosurgery), is an internationally recognised Indian neurosurgeon, microsurgical anatomist, inventor and educator. Born in Alappuzha, Kerala, in 1975, he completed his MBBS and MCh in Neurosurgery at Christian Medical College, Vellore, followed by a fellowship in skull base and vascular neurosurgery at Fujita Health University, Nagoya, Japan. The Japanese microsurgical philosophy he absorbed there, with its emphasis on meticulous anatomical dissection, minimal brain retraction and extensive laboratory practice, remains central to his approach.
He is Director of Neurosciences at Parul Institute of Medical Sciences & Research, Vadodara, and Director of the Institute of Neurosciences at KIMS, Karad. He previously directed the Nobel Institute of Neurosciences in Biratnagar, Nepal. He is also General Counsellor of the Asian Congress of Neurological Surgeons (ACNS), Chairperson of the WFNS Innovation & Technology Committee, and a member of the editorial board of Interdisciplinary Neurosurgery.
He is best known for cisternostomy, a microsurgical technique introduced in 2013 for severe traumatic brain injury. It involves opening the basal cisterns to restore cerebrospinal fluid circulation and reduce brain swelling, and is proposed as an alternative to decompressive hemicraniectomy. It is linked to his CSF-Shift Edema Theory and his Brain Cooling and Cleaning Theory, which describe the role of CSF in brain swelling, heat dissipation and waste clearance. His skull-base work includes refinements of the transcavernous, modified Kawase and petroclival approaches, along with newer corridors such as the Mosaic Approach (a multiportal orbital-suprabrow route) and the ExPaJUF approach to the jugular foramen. He has authored more than 50 publications, including a textbook on cisternostomy.His technology portfolio spans ultramicroneurosurgery, exoscope-based surgery and AI-enhanced visualisation, including the Sanma Yoko robotic exoscope, co-developed with Aesculap, and the “Hypervision” concept of AI within the surgical field.
He has also proposed Medharanya, an integrated perioperative system, and NETRA, an AI-augmented neurosurgical ICU architecture. His devices and instruments include the Santvana Retractor, the Water Knife, a portable endovascular robot and an autostop sensor drill. As founder of Neurosurgery Coach, he runs a global training platform of fellowships, cadaveric workshops and online teaching. It aims to make advanced microsurgical skills available beyond major academic centres. His honours include the Huashan International Honor Award (2022).
Beyond the operating room, he writes and speaks on consciousness, time and human performance. These interests include The Time Machine Inside You and the longevity philosophy The Flight at Fifty, which gave rise to the Iypeathletiq brand. His guiding vision is an operating room where technology enhances, rather than replaces, the surgeon’s judgement.
“I am delighted to announce the appointment of senior world-class advisors to the Group. These are distinguished leaders with outstanding records in their fields, and we are honoured to have them join us.
Their experience, insight and global perspective will strengthen our direction as we continue to build solutions that integrate diagnostics, preventive care and wellness. With their guidance and your continued commitment, we will bring more world-class, distinctive products into the Group.” Ravindran Govindan, Executive Chairman and Managing Director.
****
